May 05, 2023 | Supply Chain Strategy read
Das neue Gesetz über die Sorgfaltspflicht in der Lieferkette in Deutschland verpflichtet die Unternehmen zur Einhaltung der Menschenrechte und ethischer Praktiken innerhalb ihrer Lieferketten.
May 05, 2023 | Supply Chain Strategy read
The new German Supply Chain Act (LkSG), which came into effect in January 2023, is a significant development in Germany’s efforts to promote corporate social responsibility and prevent human rights violations in the supply chain.
While the law currently only applies to companies with more than 3,000 employees, from 2024 it will also affect companies with more than 1,000 employees.
May 03, 2023 | Procurement Strategy read
Among the 2023 ProcureCon CPO report’s findings – the growing importance of source-to-pay (S2P), 81% of survey respondents indicated that enhancing the speed and efficiency of S2P activities was a high priority over the next 12 months.
Reducing operational costs came in only slightly behind in importance at 71%.
May 03, 2023 | Procurement Strategy read
Through the first few months of 2023, it is clearer than ever that the role of the CPO has changed since the start of the pandemic. With global supply chain disruptions, CPOs are playing a more prominent and strategic role in their organizations.
What’s on the CPO’s agenda for 2023?
April 25, 2023 | Supply Chain Strategy read
Ocean freight rates have cooled substantially in 2023. Retailer stockpiling, which outpaced sales growth last year, resulted in reduced demand for new merchandise from overseas suppliers. Ocean carriers are now faced with excess capacity and are scrambling to sell space to big shippers, particularly out of Asia.
April 20, 2023 | Supply Chain Strategy read
Supply chain volatility is now at its lowest since mid-2020. Moreover, green shoots are showing as demand improves in the United States, the European Union, and especially Asia, according to the March indicators of the GEP Global Supply Chain Volatility Index.
April 19, 2023 | Pharma and Life Sciences read
Pharmaceutical and life sciences supply chains are recovering from the disruptions of the last few years and producing groundbreaking innovation despite ongoing pressures.
Between macroeconomic factors such as inflation that are creating pricing pressures to an increased focus on ESG goals, supply chain and procurement teams are today expected to address traditional metrics such as cost savings and efficiency as well as be in line with emerging trends.
What are the top concerns emerging in pharma and life sciences and how are leading companies tackling them?
